
PHAR · Egyptian International Pharmaceutical Industries Co.
114.10
EGPUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
EGP19.54B
PE
8.70
EV/EBITDA
8.2
DIV Yield
4.5%
Payout Ratio
39%
MQV Rating
4Weak
As at 07/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- HALO 100
- HALO 200
- HALO 50
- HALO All
- HALO Price Momentum
Key Fundamentals
EPS 3 yr Growth
78.40%
EBITDA Margin
26.10%
Operating Cashflow
£1,245m
Free Cash Flow Return
12.80%
ROIC
14.80%
Interest Coverage
1.80
Quick Ratio
0.70
Performance
52 weeks range
Low 65 - 178.99
Trade Value (12mth)
US$330,012.00
1 week
2.03%
1 month
-11.74%
YTD
48.39%
1 year
143.79%
All time high
178.99
Additional Data
Shares Outstanding (Fully Diluted)
169m
HALO Sector
Healthcare
Next Company Report Date
15-Mar-27
Next Ex Dividend Date
28-Apr-26
Next Dividend Pay Date
30-Sep-26
Reporting Currency
EGP
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Very Strong
Earnings
Neutral
Growth
Earnings
Very Weak
Dividends
Neutral
Quality
Capital Efficiency
Weak
Balance Sheet
Very Weak
Valuation
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Arab Company for Drug Industries & Medical Appliances | Holding Company |
| Federation of Medical Professions Syndicates | Private Company |
| Medical Professions Investment Co. | Private Company |
| Gamal Abdelkader Abdelbaser Abdelkader | Individual |
| Egyptian Steel Group | Private Company |